POLR2J3 Human

Polymerase II Polypeptide J3 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Identity and Genomic Context

Official Symbol: POLR2J3 (HGNC:33853)
Chromosomal Location: 7q22.1 (GRCh38.p14 assembly)
Protein Uniprot ID: Q9H1A7 (DNA-directed RNA polymerase II subunit RPB11-b2)

POLR2J3 belongs to the RNA polymerase II subunit 11 (RPB11) gene family, which includes three clustered genes (POLR2J, POLR2J2, POLR2J3) and a pseudogene on chromosome 7. It contributes to the assembly of the Pol II core, a 12-subunit complex critical for mRNA synthesis .

Protein Structure and Functional Role

POLR2J3 forms part of the RPB11 subunit, interacting with POLR2C (RPB3) to stabilize the polymerase’s DNA-binding domain . Key structural features:

  • Domain: Contains conserved regions for dimerization with POLR2C.

  • Post-Translational Modifications: Predicted phosphorylation sites regulate transcriptional activity .

Functional Role:

  • Facilitates Pol II assembly and DNA template binding .

  • Supports transcription elongation and termination via interactions with other subunits (e.g., RPB1, RPB5) .

Tissue Expression Profile

POLR2J3 exhibits broad but variable expression across human tissues (Table 1) .

TissueExpression LevelKey Observations
LungHighUbiquitous in bronchial epithelium
LiverModerateDetected in hepatocytes
Cerebral CortexLowLimited neuronal expression
Lymph NodeModerateExpressed in immune cells
ProstateHighElevated in glandular epithelial cells

Clinical Significance in Cancer

POLR2J3 is implicated in cancer progression, particularly in laryngeal squamous cell carcinoma (LSCC):

  • Prognostic Biomarker: High POLR2J3 expression correlates with metastasis and poor survival (HR = 1.82, p < 0.001) .

  • Mechanistic Role: Promotes tumor invasiveness by dysregulating transcription of metastasis-related genes (e.g., MYH11) .

  • Validation: RT-qPCR and immunohistochemistry (IHC) confirmed elevated POLR2J3 levels in metastatic LSCC tissues versus non-metastatic controls .

Risk Model for LSCC Prognosis

A 2023 Nature study developed a prognostic model integrating POLR2J3 and MYH11 :

  • AUC Values: 0.89 (1-year), 0.85 (3-year), 0.82 (5-year survival prediction).

  • Nomogram Utility: Combined POLR2J3 expression, lymph node status (N), and tumor stage achieved 83% accuracy in survival prediction .

Disease Associations Beyond Cancer

  • Viral Susceptibility: POLR2J3’s interaction with viral DNA sensors (e.g., cGAS-STING) is theorized to influence immune responses, though direct evidence is lacking .

  • Developmental Disorders: Mutations in related Pol II subunits (e.g., POLR2A) are linked to neurodevelopmental defects, highlighting POLR2J3’s potential indirect contributions .

Future Research Directions

  1. Mechanistic Studies: Elucidate POLR2J3’s role in transcription elongation and chromatin remodeling.

  2. Therapeutic Targeting: Explore small-molecule inhibitors of POLR2J3 for metastatic cancers.

  3. Animal Models: Generate POLR2J3 knockout mice to study developmental impacts.

Product Specs

Introduction
DNA-directed RNA polymerase II subunit RPB11-b2 (POLR2J3) belongs to the eukaryotic RPB11 RNA polymerase subunit family. POLR2J (DNA-directed RNA polymerase II subunit J) has three variants: POLR2J1 (RPB11-a), POLR2J2 (RPB11-b1), and POLR2J3 (RPB11-b2). POLR2J3 is a DNA-dependent RNA polymerase that catalyzes the transcription of DNA into RNA, using the four ribonucleoside triphosphates as substrates.
Description
Recombinant human POLR2J3, produced in E. coli, is a single polypeptide chain containing 138 amino acids (residues 1-115) with a molecular weight of 15.5 kDa. POLR2J3 has a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution.
Formulation
The POLR2J3 solution (0.5 mg/mL) is supplied in 20 mM Tris-HCl buffer (pH 8.0), 0.2 M NaCl, 1 mM DTT, and 40% glycerol.
Stability
For short-term storage (2-4 weeks), store at 4°C. For long-term storage, store frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 95% by SDS-PAGE analysis.
Synonyms
Polymerase (RNA) II (DNA Directed) Polypeptide J3, DNA-Directed RNA Polymerase II Subunit 11, DNA-Directed RNA Polymerase II Subunit RPB11-B2, DNA-Directed RNA Polymerase II Subunit J3, RNA Polymerase II Subunit B11-B2, POLR2J2, RPB11b2, RPB11b1.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMNAPPAF ESFLLFEGEK ITINKDTKVP NACLFTINKE DHTLGNIIKS QLLKDPQVLF AGYKVPHPLE HKIIIRVQTT PDYSPQEAFT NAITDLISEL SLLEERFRTC LLPLRLLP

Q&A

What is POLR2J3 and how is it related to the RNA polymerase II complex?

POLR2J3 (polymerase RNA II DNA directed polypeptide J3) is a member of the RNA polymerase II subunit 11 gene family. It belongs to a cluster of three related genes on chromosome 7q22.1, with an additional pseudogene on chromosome 7p13 . The founding member of this family encodes a subunit of RNA polymerase II, which is the polymerase responsible for synthesizing messenger RNA in eukaryotes. POLR2J3 produces multiple alternatively spliced transcripts that potentially express isoforms with distinct C-termini compared to the original DNA directed RNA polymerase II polypeptide J .

How is POLR2J3 gene expression regulated?

POLR2J3 undergoes complex post-transcriptional regulation. Most or all POLR2J3 variants are spliced to include additional non-coding exons at the 3' end, making them potential candidates for nonsense-mediated decay (NMD) . This regulatory mechanism suggests tight control over POLR2J3 expression. Research indicates that POLR2J3 expression varies across tissues and cell lines, as evidenced by data from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles and CCLE Cell Line Gene CNV Profiles . Methods to study this regulation include RNA-seq, which can identify tissue-specific expression patterns, and CRISPR-based approaches to manipulate expression levels.

What experimental methods are recommended for detecting POLR2J3 expression in human cell lines?

For detecting POLR2J3 expression in human cell lines, researchers should consider:

  • RT-qPCR: Design primers specific to POLR2J3 that can distinguish it from other family members (POLR2J and POLR2J2).

  • RNA-seq: This provides comprehensive transcriptome analysis and can detect alternatively spliced variants.

  • Western blotting: Using antibodies against POLR2J3, though specificity may be challenging given the high sequence similarity with other family members.

  • Immunoprecipitation: To isolate POLR2J3-containing complexes for subsequent analysis.

When designing experiments, researchers should be aware that POLR2J3 has sequence similarity with POLR2J2 (also known as RPB11B2) , which may complicate specific detection.

How can researchers distinguish between POLR2J3 and its paralogues (POLR2J and POLR2J2) in functional studies?

Distinguishing between POLR2J3 and its paralogues requires careful experimental design:

  • CRISPR-based approaches: Targeted knockout or activation of POLR2J3 can be achieved using gene-specific gRNAs. Commercial kits such as the POLR2J3 CRISPRa kit are available for gene activation studies . When designing gRNAs, ensure they target unique regions that differ from paralogues.

  • Isoform-specific detection: Design PCR primers or RNA probes that target the unique 3' regions of POLR2J3 transcripts.

  • Mass spectrometry: For protein-level discrimination, use targeted proteomic approaches focusing on peptides unique to POLR2J3.

  • Functional complementation: In knockout studies, rescue experiments with POLR2J3-specific constructs can confirm phenotypes are due to POLR2J3 specifically.

Remember that POLR2J3 shares significant sequence homology with POLR2J2 (RPB11B2) and POLR2J, requiring careful validation of specificity in all approaches .

What is the significance of nonsense-mediated decay (NMD) in POLR2J3 transcript regulation and how can it be experimentally addressed?

POLR2J3 transcripts include additional non-coding exons at the 3' end, making them candidates for nonsense-mediated decay (NMD) . This raises important questions about whether functional proteins are produced in vivo.

To experimentally address this:

  • NMD inhibition studies: Treat cells with NMD inhibitors (e.g., cycloheximide or UPF1 knockdown) and measure changes in POLR2J3 transcript levels using RT-qPCR or RNA-seq.

  • Polysome profiling: Determine whether POLR2J3 mRNAs associate with polysomes, indicating active translation.

  • Reporter assays: Construct reporters containing the 3' regions of POLR2J3 transcripts to quantify NMD efficiency.

  • Ribosome profiling: Assess translation efficiency and potential premature termination codons that trigger NMD.

Understanding NMD regulation of POLR2J3 may provide insights into how cells control RNA polymerase II subunit composition, potentially affecting transcriptional regulation across the genome.

What is known about POLR2J3's role in transcriptional pausing and how can researchers investigate this function?

While direct evidence for POLR2J3's role in transcriptional pausing is limited in the provided search results, research on RNA polymerase SI3 domain shows it modulates global transcriptional pausing and pause-site fluctuations . This provides a framework for investigating POLR2J3's potential involvement in similar processes.

Methodological approaches:

  • NET-seq (Native Elongating Transcript sequencing): This technique can map RNA polymerase pause sites genome-wide with nucleotide resolution, as demonstrated in studies of polymerase pausing .

  • In vitro transcription assays: Using purified components with wild-type or mutant POLR2J3 to assess effects on transcription rate and pausing.

  • CRISPR-based manipulation: Use POLR2J3 activation (CRISPRa) or knockout systems followed by global analysis of transcription dynamics.

  • ChIP-seq for POLR2J3: Map genome-wide occupancy to identify potential pause sites where POLR2J3-containing polymerase complexes accumulate.

  • Nascent RNA structure analysis: Since pause hairpins (PHs) can influence pausing , techniques like SHAPE-seq could reveal connections between RNA structure and POLR2J3-mediated pausing.

What control experiments should be included when studying POLR2J3 function using CRISPR-based approaches?

When using CRISPR-based approaches to study POLR2J3:

  • Scramble controls: Include non-targeting gRNA controls (e.g., the scramble vector provided in CRISPRa kits) .

  • Paralog controls: Include conditions targeting related genes (POLR2J, POLR2J2) to distinguish paralog-specific effects.

  • Rescue experiments: Reintroduce POLR2J3 expression in knockout cells to confirm phenotype specificity.

  • Off-target validation: Validate potential off-target effects using:

    • Secondary gRNAs targeting different regions of POLR2J3

    • Whole-genome sequencing to identify unintended modifications

    • RNA-seq to assess global transcriptional changes

  • Efficiency verification: Quantify knockout or activation efficiency using RT-qPCR, Western blotting, or functional assays.

Remember that the efficiency of CRISPR activation can be affected by many factors, including "nucleosome occupancy status, chromatin structure and the gene expression level of the target" .

How can researchers investigate the potential functional consequences of POLR2J3 variants in human disease contexts?

To investigate POLR2J3 variants in disease:

  • Variant identification: Use public databases and next-generation sequencing to identify POLR2J3 variants in patient cohorts.

  • Functional prediction: Apply bioinformatic tools to predict variant effects on:

    • Protein structure and stability

    • RNA splicing patterns

    • NMD efficiency

    • Protein-protein interactions within the polymerase complex

  • Cell model systems: Create isogenic cell lines expressing disease-associated variants using CRISPR base editing or traditional knock-in approaches.

  • Transcriptome analysis: Compare global transcription patterns between wild-type and variant-expressing cells using RNA-seq.

  • Polymerase complex integrity: Use co-immunoprecipitation and mass spectrometry to assess whether variants affect POLR2J3 incorporation into the RNA polymerase II complex.

This methodological framework can help determine whether POLR2J3 variants contribute to disease phenotypes through altered transcriptional regulation.

What technical challenges exist when expressing recombinant POLR2J3 protein for structural or biochemical studies?

Expressing recombinant POLR2J3 presents several technical challenges:

  • Expression system selection: While bacterial systems offer high yield, eukaryotic systems (insect or mammalian cells) may provide better folding and post-translational modifications.

  • Solubility optimization: POLR2J3 may require:

    • Fusion tags (His, GST, MBP) to improve solubility

    • Co-expression with interacting partners from the polymerase complex

    • Optimized buffer conditions during purification

  • Functional validation: Confirm that recombinant POLR2J3 retains biological activity through:

    • In vitro transcription assays

    • Binding studies with known interaction partners

    • Structural characterization

  • Stability considerations: Commercial recombinant POLR2J3 protein is available as a Full Length protein in the 1 to 115 amino acid range , suggesting this construct represents a stable form suitable for biochemical studies.

  • Specificity verification: Given the sequence similarity with paralogs, confirmation of protein identity using mass spectrometry is essential.

How should researchers interpret RNA-seq data for POLR2J3 given its alternative splicing and NMD potential?

When analyzing RNA-seq data for POLR2J3:

  • Isoform-level quantification: Use tools like RSEM or Salmon that account for transcript isoforms rather than gene-level quantification.

  • Junction analysis: Specifically examine reads spanning exon-exon junctions to identify all splice variants.

  • NMD-sensitive analysis pipeline:

    • Compare data from NMD-inhibited and control samples

    • Look for stabilization of transcripts with premature termination codons

    • Quantify isoform ratios to identify NMD-sensitive variants

  • Validation strategies:

    • RT-PCR to confirm specific splice junctions

    • Targeted quantitative RT-PCR for abundance estimation

    • Long-read sequencing (PacBio, Nanopore) to resolve complex isoforms

Remember that standard RNA-seq processing pipelines may not adequately capture the complexity of POLR2J3 transcripts, particularly those subject to NMD.

What functional genomics approaches can reveal POLR2J3's role in transcription regulation networks?

To uncover POLR2J3's role in transcriptional networks:

  • ChIP-seq and CUT&RUN: Map genome-wide binding of POLR2J3-containing RNA polymerase II complexes.

  • GRO-seq/PRO-seq: Quantify nascent transcription to identify genes affected by POLR2J3 perturbation.

  • Hi-C and ChIA-PET: Investigate potential roles in chromatin architecture and enhancer-promoter interactions.

  • Integrative analysis:

    • Combine POLR2J3 binding with expression data

    • Identify transcription factor co-occurrence patterns

    • Analyze pausing indices and elongation rates at POLR2J3-bound genes

  • Network analysis: Use tools like WGCNA to identify gene modules co-regulated with POLR2J3 expression.

POLR2J3 has 2,244 functional associations with biological entities spanning 6 categories extracted from 44 datasets , suggesting extensive involvement in diverse cellular processes that can be mapped through these approaches.

How might single-cell technologies advance our understanding of POLR2J3 function in heterogeneous cell populations?

Single-cell technologies offer unique opportunities for POLR2J3 research:

  • scRNA-seq: Can reveal cell type-specific expression patterns of POLR2J3 and identify rare cell populations where it may play critical roles.

  • scATAC-seq: When integrated with POLR2J3 perturbation studies, can reveal effects on chromatin accessibility.

  • Spatial transcriptomics: Can map POLR2J3 expression in tissue contexts, potentially identifying region-specific functions in organs like the brain, where expression has been reported in the Allen Brain Atlas .

  • Multi-omics integration: Combining single-cell transcriptomics with proteomics or epigenomics can provide a more comprehensive view of POLR2J3's role in cellular heterogeneity.

  • Lineage tracing: When combined with POLR2J3 manipulation, can reveal developmental or differentiation trajectories affected by altered expression.

These approaches may be particularly valuable given the evidence of differential POLR2J3 expression across tissues and cell types .

What is the potential role of POLR2J3 in modulating RNA polymerase II response to cellular stress?

Investigating POLR2J3's role in stress response:

  • Stress induction experiments: Expose cells to various stressors (heat shock, oxidative stress, UV damage) and monitor POLR2J3 expression, localization, and polymerase incorporation.

  • Stress granule association: Determine whether POLR2J3 is sequestered in stress granules during cellular stress using immunofluorescence and biochemical fractionation.

  • Stress-responsive transcription: Compare transcriptional changes during stress between wild-type and POLR2J3-manipulated cells, focusing on:

    • Heat shock genes

    • Unfolded protein response

    • DNA damage response

    • Oxidative stress genes

  • Post-translational modifications: Investigate whether POLR2J3 undergoes stress-induced modifications using mass spectrometry-based proteomics.

Understanding POLR2J3's potential role in stress response could provide insights into how RNA polymerase II activity adapts to changing cellular conditions.

Product Science Overview

Gene and Protein Structure

The POLR2J3 gene produces multiple, alternatively spliced transcripts that potentially express isoforms with distinct C-termini compared to the DNA-directed RNA polymerase II polypeptide J . The human recombinant form of POLR2J3 is typically produced in Escherichia coli (E. coli) and is a single polypeptide chain containing 138 amino acids, with a molecular mass of approximately 15.5 kDa . This recombinant protein is often fused to a 23 amino acid His-tag at the N-terminus to facilitate purification .

Function and Mechanism

POLR2J3 is a component of the RNA polymerase II complex, which synthesizes messenger RNA (mRNA) precursors and many functional non-coding RNAs. RNA polymerase II is the central component of the basal transcription machinery in eukaryotic cells. It is composed of mobile elements that move relative to each other, with RPB11 (another name for POLR2J3) being part of the core element with the central large cleft .

Biological Significance

The transcription of DNA into RNA by RNA polymerase II is a critical step in gene expression, influencing various cellular processes and functions. POLR2J3, as a subunit of this complex, plays a role in ensuring the proper transcription of genetic information. Disruptions or mutations in the POLR2J3 gene can potentially lead to various diseases, although specific associations are still being studied .

Applications in Research

Recombinant POLR2J3 is widely used in research to study the mechanisms of transcription and the role of RNA polymerase II in gene expression. The availability of human recombinant POLR2J3 allows researchers to conduct detailed biochemical and structural analyses, contributing to our understanding of transcriptional regulation and its implications in health and disease .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.